Skip to main content
. 2017 Feb 21;9(4):233–247. doi: 10.14740/jocmr2761w

Table 3. Factors Up- and Down-Regulated After IGF-1 Gene Transfer in Cirrotic Patients (Modified From Bonefeld and Moller, Liver Int. 2011).

Up-regulated hepatoprotective factors Down-regulated profibrogenic factors
HGF Hepatocyte growth factor Activated HSC Activated hepatic stellate cells
MMPs Matrix metalloproteases αSMA α-smooth muscle actin
HNF4α Hepatocyte nuclear factor 4α TGF-β Transforming growth factor-β
STAT3a Signal transducer and activator of transcription 3a STAT3b Signal transducer and activator of transcription 3a
Egfr Epidermal growth factor receptor TIM1 and TIM2 Tissue inhibitors of MMPs
Hnf6 Hepatocyte nuclear factor 6 PDGF Platelet-derived growth factor
Prlr Prolactin receptor CTGF Connective tissue growth factor
Lifr Leukemia inhibitory factor receptor WT-1 Wilm’s tumor 1

Same factors could be involved in the positive clinical outcome seen when supplementing with rhIGF-1.